Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”

Detalles Bibliográficos
Autores principales: Chen, Shuang, Jiang, Hongmei, Peng, Hanhui, Wu, Xiaosong, Fang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311822/
https://www.ncbi.nlm.nih.gov/pubmed/30647807
http://dx.doi.org/10.1155/2018/1897257
_version_ 1783383677340745728
author Chen, Shuang
Jiang, Hongmei
Peng, Hanhui
Wu, Xiaosong
Fang, Jun
author_facet Chen, Shuang
Jiang, Hongmei
Peng, Hanhui
Wu, Xiaosong
Fang, Jun
author_sort Chen, Shuang
collection PubMed
description
format Online
Article
Text
id pubmed-6311822
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63118222019-01-15 Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases” Chen, Shuang Jiang, Hongmei Peng, Hanhui Wu, Xiaosong Fang, Jun Oxid Med Cell Longev Corrigendum Hindawi 2018-12-13 /pmc/articles/PMC6311822/ /pubmed/30647807 http://dx.doi.org/10.1155/2018/1897257 Text en Copyright © 2018 Shuang Chen et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Chen, Shuang
Jiang, Hongmei
Peng, Hanhui
Wu, Xiaosong
Fang, Jun
Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title_full Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title_fullStr Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title_full_unstemmed Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title_short Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”
title_sort corrigendum to “the utility of ovotransferrin and ovotransferrin-derived peptides as possible candidates in the clinical treatment of cardiovascular diseases”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311822/
https://www.ncbi.nlm.nih.gov/pubmed/30647807
http://dx.doi.org/10.1155/2018/1897257
work_keys_str_mv AT chenshuang corrigendumtotheutilityofovotransferrinandovotransferrinderivedpeptidesaspossiblecandidatesintheclinicaltreatmentofcardiovasculardiseases
AT jianghongmei corrigendumtotheutilityofovotransferrinandovotransferrinderivedpeptidesaspossiblecandidatesintheclinicaltreatmentofcardiovasculardiseases
AT penghanhui corrigendumtotheutilityofovotransferrinandovotransferrinderivedpeptidesaspossiblecandidatesintheclinicaltreatmentofcardiovasculardiseases
AT wuxiaosong corrigendumtotheutilityofovotransferrinandovotransferrinderivedpeptidesaspossiblecandidatesintheclinicaltreatmentofcardiovasculardiseases
AT fangjun corrigendumtotheutilityofovotransferrinandovotransferrinderivedpeptidesaspossiblecandidatesintheclinicaltreatmentofcardiovasculardiseases

Ejemplares similares